Quince (QNCX): Rega marang dodolan

Logo korporat perusahaan Quince Therapeutics (QNCX)

Quince Therapeutics is developing an erythrocyte-based drug delivery platform, mitigating risks through program diversification. Simultaneously, a focus on therapies for rare genetic pathologies ensures high R&D relevance. The price-to-sales valuation reflects current dynamics, with the metric standing at . The operating model relies on the full outsourcing of production and trials, eliminating capital expenditures for laboratories.

Quince - Multiplikator P/S QNCX (periode 04.07.2022 - 16.11.2026)

Rincian metrik lan analitis perusahaan Quince Therapeutics Inc (QNCX)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:Quince Therapeutics
Barang utama Quince Therapeutics, Inc.

The development of Quince Therapeutics (QNCX) relies on the creation of targeted drug delivery systems and the successful completion of clinical trials. The price-to-sales ratio digitizes the market value of every dollar of sales, reflecting investor confidence in the potential of future developments. This multiple allows for an assessment of the asset's premium, excluding the influence of short-term market noise. By analyzing P/S levels on the chart, one can determine the fundamental attractiveness of the business relative to its current operating revenues.

Karo sapa Quince Therapeutics saingan

Rasio rega marang pendapatan ASND (Ascendis Pharma AS)|Rasio rega marang pendapatan madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan soleno.life (SLNO)|Kapitalisasi marang pendapatan Amicus Therapeutics FOLD|Rasio kapitalisasi pasar marang pendapatan 89bio Inc|Multiplikator P/S Agios Pharmaceuticals, Inc. AGIO|GPCR: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan MiMedx Corp MDXG|RZLT (Rezolute Corp) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan LXRX|MBX (MBX Biosciences) - Multiplikator P/S|Kapitalisasi marang pendapatan Altimmune Inc (ALT)|Kapitalisasi marang pendapatan AARD (Aardvark Therapeutics Corp)|Kapitalisasi marang pendapatan Sagimet SGMT|Multiplikator P/S BIOA (BioAge Labs)|Multiplikator P/S Biomea Fusion BMEA|GUTS - Rasio rega marang pendapatan|Rega marang dodolan vTv Therapeutics|ATPC (agapeatpgroup.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan PLUR|Kapitalisasi marang pendapatan SYBX|LPCN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MTNB|SPRB - Rega marang dodolan|Multiplikator P/S GLTO (Galecto Corporation)|Rasio kapitalisasi pasar marang pendapatan CTCX|Lumos Therapeutics - Multiplikator P/S|ONVO: Rasio rega marang pendapatan|Radius Recycling (RDUS) - Rasio rega marang pendapatan